On Monday, Expeditors International of Washington (NASDAQ:EXPD)’s shares declined -0.06% to $49.25.
Expeditors International of Washington, Inc. (EXPD) declared that it will hold an Investor Day on Wednesday, September 2, 2015 at the Company’s Global Headquarters in Seattle, Washington. The meeting will commence at 9:00 am to 12:00 pm (PDT) and will comprise presentations from the Company’s Chief Executive Officer, Chief Financial Officer and other senior executives. As space is limited, the presentations will be simultaneously webcast.
Expeditors International of Washington, Inc. provides logistics services. The company’s services comprise air and ocean freight consolidation and forwarding, customs clearance, warehousing and distribution, purchase order administration, vendor consolidation, time-definite transportation services, cargo insurance, and other logistics solutions. It acts as a freight consolidator or as an agent for the airline, which carries the shipment.
58.com Inc (ADR) (NYSE:WUBA)’s shares dropped -1.36% to $49.90.
58.com Inc (ADR) (NYSE:WUBA) stated its unaudited financial results for the first quarter ended March 31, 2015.
First Quarter 2015 Financial Highlights
- Total revenues were US$87.1 million, an 80.5% enhance from the same period last year; surpassing guidance of US$82.0 to US$84.0 million.
- Gross margin was 93.1%, contrast with 94.9% during the same quarter of 2014.
- Net loss attributable to 58.com Inc. was US$52.4 million, contrast with net income attributable to 58.com Inc. of US$2.3 million in the same period of last year.
- Non-GAAP net loss attributable to 58.com Inc.[1] was US$47.8 million, contrast with non-GAAP net income attributable to 58.com Inc. of US$3.3 million in the same quarter of 2014.
- Basic and diluted losses per ADS[2] attributable to ordinary shareholders were US$0.59. One ADS represents two Class A ordinary shares.
58.com Inc. operates an online marketplace for local merchants and consumers in the People’s Republic of China. Its online marketplace enables local merchants and consumers to connect, share information, and conduct business.
At the end of Monday’s trade, Motorola Solutions Inc (NYSE:MSI)‘s shares surged 0.45% to $65.27.
Motorola Solutions (MSI) declared that it has commenced a modified “Dutch Auction” tender offer to repurchase shares of its common stock for an aggregate purchase price of up to $2 billion (subject to a customary enhance if the tender offer is oversubscribed).
Motorola Solutions stockholders may tender all or a portion of their shares (1) at a price specified by the tendering stockholder of not less than $61.00 per share and not more than $66.50 per share or (2) without specifying a purchase price, in which case their shares will be purchased at the purchase price determined in accordance with the tender offer. When the tender offer expires, Motorola Solutions will determine the lowest price within the range of prices specified above that allows it to purchase up to an aggregate of $2 billion of its common stock.
Motorola Solutions, Inc. provides mission-critical communication infrastructure, devices, software, and services in North America, Latin America, the Asia Pacific, the Middle East, Europe, and Africa. The company operates in two segments, Products and Services. The Products segment offers a portfolio of network infrastructure, devices, accessories, and software for government, public safety and first-responder agencies, municipalities, and commercial and industrial customers.
Organovo Holdings Inc (NYSEMKT:ONVO), ended its Monday’s trading session with 3.05% gain, and closed at $2.70.
Organovo Holdings, Inc. (ONVO “), stated its financial results for the first quarter of fiscal 2016 ended June 30, 2015.
Recent Corporate Highlights Comprised of:
- Celebrated the successful launch of its exVive3DTM Human Liver Tissue, with an declarement of the launch results showing about $2 million in total contract bookings as of June 9, 2015.
- Presented data on the Company’s in vitro three-dimensional kidney tissue at the 2015 Experimental Biology conference in Boston, Massachusetts, demonstrating fully human kidney proximal tubular tissues were generated that were three-dimensional, and compriseed of multiple tissue-relevant cell types arranged to recapitulate the renal tubular/interstitial interface. This breakthrough result demonstrated a proof of concept that kidney is on the way to becoming another core commercial tissue for Organovo.
- Declared a partnership with L’Oreal USA, wherein L’Oreal’s U.S.-based global Technology Incubator and Organovo will leverage Organovo’s proprietary NovoGen Bioprinting Platform and L’Oreal’s expertise in skin engineering to develop 3D printed skin tissues for product evaluation and other areas of advanced research, marking the first-ever application
Organovo Holdings, Inc., an early commercial stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
